A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer

BACKGROUND: Recently, neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil (NAC-DCF) was identified as a novel strong regimen with a high rate of pathological complete response (pCR) in advanced esophageal cancer in Japan. Predicting pCR will contribute to the therapeutic strategy and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujishima, Hajime, Fumoto, Shoichi, Shibata, Tomotaka, Nishiki, Kohei, Tsukamoto, Yoshiyuki, Etoh, Tsuyoshi, Moriyama, Masatsugu, Shiraishi, Norio, Inomata, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685591/
https://www.ncbi.nlm.nih.gov/pubmed/29136005
http://dx.doi.org/10.1371/journal.pone.0188098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685591/
https://www.ncbi.nlm.nih.gov/pubmed/29136005
http://dx.doi.org/10.1371/journal.pone.0188098

Ejemplares similares